Infliximab, CAS 170277-31-3

Description: Infliximab is a humanized antibody against tumor necrosis factor α TNF-α) that is used in the treatment of Crohn's disease and rheumatoid arthritis.

CAS Number: 170277-31-3

Molecular Weight: 149 kDa

References: Dahlén R, et al. Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.Scand J Immunol. 2013 Sep;78(3):275-84.

• Artikelnummer: TGMT9921-5mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T9921-5mg
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK